SCHEMBL7729028

SCHEMBL7729028

NCC(=O)N[C@H]1CN[C@@H](C(=O)c2nc3ccc(Cc4ccccc4)cc3[nH]2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.41
CHEK2 O96017 1/20 0.37
RAD52 P43351 1/20 0.35
UBE2N P61088 1/20 0.35
GID4 Q8IVV7 1/20 0.34
GAA P10253 2/20 0.34
PKM P14618 2/20 0.34
EGLN1 Q9GZT9 2/20 0.34
TSHR P16473 1/20 0.34
RAF1 P04049 1/20 0.34
BRAF P15056 1/20 0.34
DPP8 Q6V1X1 2/20 0.33
DPP9 Q86TI2 2/20 0.33
DPP7 Q9UHL4 2/20 0.33
DAGLA Q9Y4D2 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ABL1 P00519 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7729019 0.93 SMYD3 (0.41) SMYD3CHEK2GID4EGLN1DPP8
SCHEMBL7729522 0.86 LPAR2 (0.42) TSHRRAF1BRAFTDP1ABL1
SCHEMBL8144435 0.84 CACNA1G (0.40) RAD52UBE2NGAAPKMTSHR
SCHEMBL7732752 0.83 GID4 (0.41) SMYD3CHEK2RAD52UBE2NGID4
SCHEMBL7731211 0.82 ALDH1A1 (0.41)
SCHEMBL21436230 0.82 ALDH1A1 (0.41)
SCHEMBL7729500 0.79 ALDH1A1 (0.40) KDM4ETDP1ABL1GSK3B
SCHEMBL7723308 0.77 CACNA1G (0.40) GID4GAATSHRDPP8DPP9
SCHEMBL7723513 0.77 CACNA1G (0.40) GID4GAATSHRDPP8DPP9
SCHEMBL2067985 0.76 GID4 (0.41) SMYD3GID4EGLN1TDP1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed